How to buy Collplant Biotechnologies stock (CLGN)

Collplant Biotechnologies is a biotechnology business based in the US. Collplant Biotechnologies shares (CLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.41 – a decrease of 7.59% over the previous week. Collplant Biotechnologies employs 75 staff and has a trailing 12-month revenue of around $689,000.

Our top picks for where to buy Collplant Biotechnologies stock

Buy Collplant Biotechnologies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Collplant Biotechnologies stock price (NASDAQ: CLGN)

Use our graph to track the performance of CLGN stocks over time.

Collplant Biotechnologies shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$3.41
52-week range	$3.31 - $6.99
50-day moving average more info button	$4.09
200-day moving average more info button	$4.92
Wall St. target price	$12.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.53

Is it a good time to buy Collplant Biotechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collplant Biotechnologies price performance over time

Historical closes compared with the close of $3.675 from 2024-12-19

1 week (2024-12-13)	-0.41%
1 month (2024-11-21)	-11.76%
3 months (2024-09-20)	-20.28%
6 months (2024-06-21)	-24.15%

1 year (2023-12-21)	-30.00%
2 years (2022-12-21)	-58.14%
3 years (2021-12-21)	13.48
5 years (2019-12-20)	5.5809

Collplant Biotechnologies financials

Revenue TTM	$689,000
Gross profit TTM	$13.6 million
Return on assets TTM	-33.77%
Return on equity TTM	-61.55%
Profit margin	0%
Book value	$2.48
Market Capitalization more info button	$42.5 million

TTM: trailing 12 months

Collplant Biotechnologies share dividends

We're not expecting Collplant Biotechnologies to pay a dividend over the next 12 months.

Have Collplant Biotechnologies's shares ever split?

Collplant Biotechnologies's shares were split on a 2:3 basis on 20 November 2016 . So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Collplant Biotechnologies shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for Collplant Biotechnologies shares which in turn could have impacted Collplant Biotechnologies's share price.

Collplant Biotechnologies share price volatility

Over the last 12 months, Collplant Biotechnologies's shares have ranged in value from as little as $3.31 up to $6.99. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collplant Biotechnologies's is 0.483. This would suggest that Collplant Biotechnologies's shares are less volatile than average (for this exchange).

Collplant Biotechnologies overview

CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd.

Frequently asked questions

null
What percentage of Collplant Biotechnologies is owned by insiders or institutions?
Currently 10.16% of Collplant Biotechnologies shares are held by insiders and 12.234% by institutions. How many people work for Collplant Biotechnologies?
Latest data suggests 75 work at Collplant Biotechnologies. When does the fiscal year end for Collplant Biotechnologies?
Collplant Biotechnologies's fiscal year ends in December. Where is Collplant Biotechnologies based?
Collplant Biotechnologies's address is: Weizmann Science Park, Rehovot, Israel, 7670104 What is Collplant Biotechnologies's ISIN number?
Collplant Biotechnologies's international securities identification number is: IL0004960188 What is Collplant Biotechnologies's CUSIP number?
Collplant Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 19516R107